Assertio Holdings (ASRT) Research & Development (2019 - 2026)

Assertio Holdings' (ASRT) quarterly Research & Development came in at $454000.0 in Q1 2026, up 3.65% year-on-year from $438000.0 in Q1 2025, and down 6.58% quarter-over-quarter from $486000.0 in Q4 2025.

Assertio Holdings (ASRT) Research & Development (2019 - 2026) Analysis & Trends

Assertio Holdings has disclosed Research & Development across 6 years of filings, most recently posting $454000.0 for Q1 2026.

  • Research & Development for Q1 2026 came in at $454000.0, up 3.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (down 51.63% YoY), and the FY2025 annual result was $1.7 million, down 55.78% from the prior year.
  • Research & Development came in at $454000.0 for Q1 2026 at Assertio Holdings, down from $486000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.3 million in Q3 2023 to a low of $379000.0 in Q3 2025.
  • The 4-year median for Research & Development is $618000.0 (2023), against an average of $734083.3.
  • Across the five-year window, Research & Development surged 58.65% in 2024 and slumped 62.29% in 2025, its largest moves.
  • Assertio Holdings' Research & Development stood at $1.0 million in 2023, then climbed by 25.59% to $1.3 million in 2024, then sank by 62.21% to $486000.0 in 2025, then retreated by 6.58% to $454000.0 in 2026.
  • The last three Research & Development figures came in at $454000.0 (Q1 2026), $486000.0 (Q4 2025), and $379000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 222.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 180.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 138.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 934,363.43
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 296.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 97.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 103.35 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 39.38 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 46.94 Mn
10 Assertio Holdings 150.78 Mn 79.21 Mn 7.22 Mn 454,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 454,000.00
Dec 31, 2025 486,000.00
Sep 30, 2025 379,000.00
Jun 30, 2025 387,000.00
Mar 31, 2025 438,000.00
Dec 31, 2024 1.29 Mn
Sep 30, 2024 1.01 Mn
Jun 30, 2024 798,000.00
Mar 31, 2024 733,000.00
Dec 31, 2023 1.02 Mn
Sep 30, 2023 1.32 Mn
Jun 30, 2023 503,000.00
Dec 31, 2020 230,000.00
Sep 30, 2020 1.32 Mn
Jun 30, 2020 1.63 Mn
Mar 31, 2020 1.04 Mn
Dec 31, 2019 5.58 Mn
Sep 30, 2019 1.48 Mn
Jun 30, 2019 1.26 Mn